... VHS® Variable- Angle CHS System takes the tim...ium. , ,The VHS® Supracondylar Cable Plate is ...al femur fractures including periprosthetic fractu... variable angle of the barrel and the plate combin...
X-Hair Trephines
Corneal Trephine Punch - Stainless steel unit with titanium jaws, complete with PTFE cutting block. 1 reusable unit.
Corneal Marker - 8 blades, 2 sizes available: 7.0mm, 8.0mm. 1 piece per box
Medicine Products:(Date:8/8/2008)...., Aug. 8 /PRNewswire-USNewswire/ National Hospice...pice Foundation honor the,recipients of the 2008 C...ebrates innovation in end-of-life care and highlig...th, and scope., Award recipients were announced J...al summit in San Diego. This year,s Award winners ...
(Date:8/7/2008)...Testing men for elevated levels of prostate-specif... screening test for prostate cancer -- may be bias...deceptively low. And this bias may be creating mo...ng diagnosis, according to a new study led by inve...am Veterans Affairs (VA) Medical Center. , "We ...
(Date:8/7/2008)...sn,t require fasting, could ID millions who don,t ...g. 7 (HealthDay News) -- A widely used test to mon...uld help identify millions of people with undetect...leased by a team of experts. , The hemoglobin ...cells have been exposed to in the previous 120 day...
(Date:8/7/2008)...Md., Aug. 7 /PRNewswire-USNewswire/ -- Vapotherm, ...ucts, has received 510(k),clearance from the Food ...M), the first high flow humidification system to i...tion technology into one device for,the optimal co...r Vapotherm products are currently used in neonata...
Breaking Medicine News(10 mins):Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 2Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 3Health News:PSA screening may be biased against obese men, leading to more aggressive cancers 2Health News:Blood Sugar Test May Also Aid Diabetes Detection 2Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2(Date:8/6/2008)...ANN ARBOR, Mich., Aug. 6 /- Terumo He... the DuraHeart(TM) Left Ventricular Assist,System ...Michigan,Cardiovascular Center in Ann Arbor, Michi...M.D., Ph.D. National Co-Principal Investigator for...e world,s first third,generation left ventricular ...
(Date:8/5/2008)...WHIPPANY, N.J., Aug. 5 /- Nexgen Spin...ts for the surgical treatment of,degenerative disc...mark,approval to market the Physio-L(R) Lumbar Art...ghted that the Physio-L(R) Artificial Disc Prosthe...Clemow, Ph.D., President and CEO,of Nexgen Spine. ...
(Date:8/5/2008)...5 Million Interferon-Beta-CTP Development Program ...a Special Grant From the Israeli Office of the ...NA, Israel, Aug. 5 /- Modig... that its Israeli-based R&D subsidiary,has receive...fice of the,Chief Scientist ("OCS") in support of ...
(Date:8/5/2008)...MONMOUTH JUNCTION, N.J., Aug. 5 /- Mi...ced that the first clinical milestone in its,colla...ffiliate, has been,achieved, triggering the first ...roDose,s dry powder inhaler (DPI) technology annou...tiation by Merck of a Phase I clinical,study of an...
Breaking Medicine Technology:First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial 2Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 2Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 3Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 4MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc. 2Unilever Extends Their GeneGo MetaCore License 6404 1Unilever Extends Their GeneGo MetaCore License 6404 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 1Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 4Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle 3932 1Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle 3932 2Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle 3932 3Normal looking sperm may have serious damage 3B scientists urge more care in selection 3930 1Normal looking sperm may have serious damage 3B scientists urge more care in selection 3930 2Normal looking sperm may have serious damage 3B scientists urge more care in selection 3930 3...agonist shown to be therapeutically effective in a...PENHAGEN, 18 April 2007 - Santaris Pharma, the Dan...s, yesterday,presented encouraging data at the Ame...ng in Los Angeles, showing that SPC2996, the,Compa...ctive in a,preclinical model of human Chronic Lymp...
...Calif., April 18, 2007 /PRNewswire-FirstCall/ -- K...linical data on its,proprietary nuclear export inh...ting and long-lasting anticancer activity with a,h... xenograft,cancer models. , Kosan,s NEIs are poten..., essential protein that exports key regulatory pr...
Other Medicine Technology:Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 2Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 3Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 4